http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0812581-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_983fa366d54b080542742d72951c002c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1bf06f55de84b78abc9a057807f7eb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
filingDate 1994-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bef498cb53939f2ac4a5e585828753d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af6798d1de594b3659eeeac07814075e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea832acb015b67d6eb1918124136fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e265c75282908e69640d057148c7be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c88803b469b034f0a16491d5d11f7fec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013f0df10cf5824fa78861fac34cf1e8
publicationDate 1996-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0812581-A
titleOfInvention Ischemic heart disease therapeutic agent
abstract (57) [Summary] [Structure] Effective amounts of diadenosine 5 ', 5 "'- A therapeutic agent for ischemic heart disease comprising p 1 , p 4 -tetraphosphate or a salt thereof with a pharmaceutically acceptable base together with a pharmaceutically acceptable carrier or diluent. [Effect] It is effective in reducing ischemia because it has an action of increasing coronary blood flow during ischemia and protecting myocardium.
priorityDate 1994-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426042384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967396
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9812759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423045122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449973617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22759563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450328021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3613359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453018404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415723756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11957521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39836
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4639902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443032
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1422

Total number of triples: 52.